Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders
- PMID: 12554828
- DOI: 10.1097/01.psy.0000040951.22044.59
Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders
Abstract
Objective: The prevalence and consequences of nonadherence to antipsychotic medications in schizophrenia and related psychotic disorders have been well described; however, little is known about adherence to medications for nonpsychiatric conditions in patients with psychotic disorders. We wished to determine medication adherence in nondemented middle-aged and older Veterans Affairs outpatients with schizophrenia or other psychotic disorders who had been prescribed oral medications for hypertension, hyperlipidemia, or diabetes.
Methods: Medication adherence was assessed by review of medication fill records for 76 patients aged 40 years and older who had been prescribed an oral antipsychotic in addition to an oral agent for hypertension (N = 60), hyperlipidemia (N = 28), or diabetes (N = 24). Up to 12 months of therapy was reviewed, and a compliant fill rate (the number of adherent fills in proportion to the total number of prescription fills) and cumulative mean gap ratio (the number of days when medication was unavailable in relation to the total number of days) were calculated for each medication.
Results: The 12-month mean compliant fill rates for antipsychotics, antihypertensives, antihyperlipidemics, and antidiabetics ranged from 52% to 64%. Nonpsychiatric medication adherence rates were similar in patients on typical vs. atypical antipsychotics and did not correlate significantly with antipsychotic adherence rates.
Conclusions: Nonadherence rates were found to be equally problematic for both antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders. Interventions to improve adherence to both antipsychotic and nonpsychiatric medications are needed.
Similar articles
-
Antipsychotic medication adherence: is there a difference between typical and atypical agents?Am J Psychiatry. 2002 Jan;159(1):103-8. doi: 10.1176/appi.ajp.159.1.103. Am J Psychiatry. 2002. PMID: 11772697
-
Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.J Med Econ. 2017 Dec;20(12):1252-1260. doi: 10.1080/13696998.2017.1365720. Epub 2017 Aug 24. J Med Econ. 2017. PMID: 28792299
-
Adherence to antihyperlipidemic medication and lipid control in diabetic Veterans Affairs patients with psychotic disorders.Psychosomatics. 2011 Jul-Aug;52(4):310-8. doi: 10.1016/j.psym.2011.03.004. Psychosomatics. 2011. PMID: 21777713
-
Using antipsychotic agents in older patients.J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.
-
Strategies for improving treatment adherence in schizophrenia and schizoaffective disorder.J Clin Psychiatry. 2010;71 Suppl 2:20-6. doi: 10.4088/JCP.9096su1cc.04. J Clin Psychiatry. 2010. PMID: 21190649 Review.
Cited by
-
Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?Schizophr Bull. 2010 Mar;36(2):428-35. doi: 10.1093/schbul/sbn106. Epub 2008 Aug 20. Schizophr Bull. 2010. PMID: 18718883 Free PMC article.
-
Medication adherence among older adults with schizophrenia.J Gerontol Nurs. 2013 Feb;39(2):26-34; quiz 35. doi: 10.3928/00989134-20130109-02. Epub 2013 Jan 18. J Gerontol Nurs. 2013. PMID: 23327119 Free PMC article.
-
[Psychiatric pharmacotherapy of older individuals with severe mental illness].Z Gerontol Geriatr. 2018 Nov;51(7):770-778. doi: 10.1007/s00391-018-1455-z. Epub 2018 Oct 9. Z Gerontol Geriatr. 2018. PMID: 30302537 Review. German.
-
Adherence of patients with schizophrenia to hypothyroidism treatment.Glob Ment Health (Camb). 2023 Dec 5;10:e91. doi: 10.1017/gmh.2023.86. eCollection 2023. Glob Ment Health (Camb). 2023. PMID: 38161742 Free PMC article.
-
Treatment of Patients with Mental Illness Amid A Global COVID-19 Pandemic.Adv Exp Med Biol. 2021;1318:759-771. doi: 10.1007/978-3-030-63761-3_42. Adv Exp Med Biol. 2021. PMID: 33973210
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous